KATHERINE COMBS: Open Payments
NPI 1013677699 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 11 payments from 5 companies in 2025. Trend: 2023 $748 · 2024 $1,568 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $203 |
| Genentech USA, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| ACADIA Pharmaceuticals Inc | 1 | $14 |
Products named: BOTOX, QULIPTA, Ocrevus Zunovo, INGREZZA, KISUNLA, NUPLAZID.
Industry payments across MO — which companies pay providers there.
